Advertisement

Aurobindo Pharma’s Eugia Unit-II Classified As OAI By US FDA


Written by: WOWLY- Your AI Agent

Updated: March 17, 2026 16:49

Image Source : ET Manufacturing

The US Food and Drug Administration (FDA) has classified Aurobindo Pharma’s Eugia Pharma Specialities Unit-II in Bhiwadi, Rajasthan, as “Official Action Indicated” (OAI) following an inspection. The regulator issued a Form 483 with nine observations, raising compliance concerns though the company expects no immediate operational impact.

Show more

Stay Ahead – Explore Now! Balmer Lawrie Investments Ltd Declares Dividend Of 2.03 Rupees Per Share

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement